Skip to main content
Clinical Trials/CTRI/2018/05/013757
CTRI/2018/05/013757
Recruiting
N/A

eoadjuvant Chemotherapy vs Neoadjuvant Chemoradiotherapy for Resectable Carcinoma Gastroesophageal junction : a Randomized Controlled Trial

Dr Shivendra Singh0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: null- Patients with resectable Carcinoma Gastroesophageal junction without clinical metastasis
Sponsor
Dr Shivendra Singh
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Shivendra Singh

Eligibility Criteria

Inclusion Criteria

  • All patients with resectable and hitologically proven adenocarcinoma of Gastroesophageal junction(type I,II,III) who are fit for surgery(ECOG performance status 0,1,2\); No Distant metastasis on PET scan and Staging Laparoscopy

Exclusion Criteria

  • Distant metastasis on Staging Laparoscopy or on PET scan; refusal for informed consent for procedure; locally unresectable tumors; tumors falling in stage cT1N0 on Endoscopic ultrasound examination

Outcomes

Primary Outcomes

Not specified

Similar Trials